Form 4 for STIM Neuronetics, Inc.
Accepted 2026-03-23 00:00:00 ET · period of report 2026-03-23 · accession 0001563602-26-000006 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026-03-23 | 2026-03-23 | STIM | REUVERS DANIEL L. | Pres, CEO | A - Grant | $0.00 | +1.50M | 1.50M | New | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2026-03-23 | A | A | 1,500,000 | $0.00 | 1,500,000 | D | — | — | (F1) Represents a restricted stock unit ("RSU") award that vests in three equal annual installments beginning on March 23, 2027, in each case subject to continuous service of the Reporting Person through such date. (F2) Each RSU represents a contingent right to receive one share of the Issuer's common stock. |